socalTECH

MARCH 15, 2018

Westlake Village-based Pray.com , which develops social networking applications for religious communities, has raised $14M in a Series A funding, the company said this week. Pray.com offers up both iOS and Android applications that let users join their preferred "faith community". and Greylock Partners. READ MORE>>.

Social Network 302

Social Network Westlake Village Networking Seed Funding 302

socalTECH

DECEMBER 15, 2020

Los Angeles-based ACELYRIN , a new startup biopharma company, announced this morning that it has raised a Series A funding. The funding came from Westlake Village BioPartners. Beth Seidenberg, MD, co-founding managing director of Westlake Village BioPartners, has joined ACELYRIN's board as part of the funding.

Westlake Village 113

Westlake Village Funding Los Angeles Startup 113

socalTECH

APRIL 29, 2021

Thousand Oaks-based Capsida Biotherapeutics, a new biotechnology company focused on using adeno-associated virus (AAV) engineering and cargo development platform to develop tissue-targeted gene therapies for multiple types of diseases, has uncloaked from stealth mode, saying it has raised $140M in total capital.

Westlake Village 113

Westlake Village Thousand Oaks Funding CalTech 113

socalTECH

JULY 5, 2017

Westlake Village-based Sienna Biopharmaceuticals , a startup biopharmaceuticals firm developing products for the medical dermatology and aesthetics market, has filed for an IPO. Sienna said it is hoping to raised up to $74.8M Morgan, Cowen, and BMO Capital Markets. Morgan, Cowen, and BMO Capital Markets.

Westlake Village 113

Westlake Village Marketing Capital Funding 113

socalTECH

JANUARY 31, 2019

Westlake Village-based Avinew , a new startup looking at developing auto insurance for the autonomous vehicle market, has raised $5M in a seed funding round, according to the company. The funding was led by Crosscut Ventures, and also included American Family Ventures, Draper Frontier, and RPM Ventures.

Westlake Village 113

Westlake Village Draper Seed Funding Activity 113

Xconomy

JANUARY 27, 2020

By month’s end, five more are anticipated to join the class of 2020 initial public offerings—and four of those are in life sciences, according to IPO research firm Renaissance Capital. Cancer drug developer Black Diamond filed IPO paperwork with regulators on Jan. 7 detailing its plans to use to the cash to finance Phase 1/2.

Westlake Village 109

Westlake Village Class Research Capital 109

Xconomy

SEPTEMBER 5, 2018

But a new venture capital firm led by industry veterans is trying to cast the City of Angels in a new light. Westlake Village BioPartners is launching today with $350 million in committed capital. Harper will start with Westlake in January after retiring from Amgen.

Westlake Village 73

Westlake Village Los Angeles Angel Venture Capital 73